AMED Amedisys


Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
The Company held its annual meeting of stockholders on Tuesday, June 8, 2021 (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on three proposals. A brief description of and tabulation of votes for each proposal are set forth below.

Proposal 1. The Company’s stockholders elected the following nine directors for a term of one year. There were 884,088 broker non-votes with respect to the proposal.

Vickie L. Capps28,034,476891,840
Molly J. Coye, MD28,373,100553,216
Julie D. Klapstein28,117,515808,801
Teresa L. Kline28,301,871624,445
Paul B. Kusserow27,516,2391,410,077
Richard A. Lechleiter28,155,797770,519
Bruce D. Perkins28,372,410553,906
Jeffrey A. Rideout, MD28,373,719552,597
Ivanetta Davis Samuels28,466,386459,930

Proposal 2. The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered public accountants for the fiscal year ending December 31, 2021. There were no broker non-votes with respect to the proposal.


Proposal 3. The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation paid to the Company’s named executive officers. There were 884,088 broker non-votes with respect to the proposal.